Antihypertensive effect and end-organ protection of flavonoids: Some insights, more questions

Journal of Hypertension

Volumn 20, Issue 9, 2002, Pages 1721-1724

  Cosentino, Francesco ^a   Volpe, Massimo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; FLAVONOID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; QUERCETIN;

ANTIHYPERTENSIVE ACTIVITY; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CORONARY RISK; ENDOTHELIUM; HYPERTENSION; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0036735850     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200209000-00013     Document Type: Note

References (45)

1. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle to acetylcholine
2. Maintenance of vascular integrity: Role of nitric oxide and other bradykinin mediators
3. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits
4. Atherosclerosis and the two faces of endothelial nitric oxide synthase
5. Atherosclerosis: An inflammatory disease
6. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
7. Antioxidants and atherosclerotic heart disease
8. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer
9. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study
10. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study
11. Antioxidant flavonols and coronary heart disease risk
12. Flavonoid intake and coronary mortality in Finland: A cohort study
13. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals
14. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women
15. Flavonols and flavones and food plants: A review
16. Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets
17. Flavonoids can replace alpha-tocopherol as an antioxidant
18. On the mechanism of antithrombotic action of flavonoids
19. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi
20. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries
21. Wine, alcohol, platelets, and the French paradox for coronary heart disease
22. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfraction, and decreased risk of myocardial infarction
23. Grape juice, but not orange or grapefruit juice inhibit platelet activity in dogs and monkeys
24. Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice
25. Natural antioxidants in grapes and wines
26. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease
27. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release
28. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through tje JNK pathway
29. Protective effect of the flavonoid quercetin in chronic nitric oxide deficient rats
30. Chronic nitric oxide inhibition model six years on
31. Vasodilator effect of quercetin on isolated rat vascular smooth muscle
32. Effects of chronic quercetin treatment on hepatic oxidative status of spontaneously hypertensive rats
33. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats
34. The isoprastanes. Current knowledge and directions for future research
35. Blood pressure and vascular effects on endothelin blockade in chronic nitric oxide deficient hypertension
36. Dietary antioxidants and risk of myocardial infarction in the elderly: The Rotterdam Study
37. Relation of serum ascorbic acid to mortality among US adults
38. Relation between plasma ascorbic acid and mortality in men and women in EPIC - Norfolk Prospective Study: A prospective population study
39. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers
40. Vitamin E supplementation and cardiovascular events in high-risk patients
41. Dietary supplementation with N-3 polyunsaturated fatty acids and vitamin E after myocardial infaction: Results of the GISSI-Prevenzione Trial
42. Low dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
43. Effects of ramipril and vitamin E on atherosclerosis: The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)
44. MRC/BHF Heart protection study of antioxidant vitamin supplementation in 20536 high-risk individuals: A randomised placebo-controlled trial
45. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: The Cerphilly Study